ProQR Therapeutics Ownership 2024 | Who Owns ProQR Therapeutics Now?
Institutional Ownership
8.34%
Insider Ownership
18.22%
Retail Ownership
73.44%
Institutional Holders
11.00
ProQR Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PRIVIUM FUND MANAGEMENT B.V. | 6.84% | 2.35% | 5,580,725 | 236,279 | 4.42% | 9,208,196 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.44% | 0.01% | 3,625,467 | - | - | 6,018,275 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 2.50% | 0.10% | 2,042,771 | -841,586 | -29.18% | 3,391,000 | Jun 30, 2024 |
| M28 CAPITAL MANAGEMENT LP | 1.25% | 2.19% | 1,019,498 | - | - | 1,692,367 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 1.11% | 0.36% | 905,582 | - | - | 1,503,266 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 1.10% | 0.47% | 900,000 | 900,000 | 100.00% | 1,494,000 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.76% | 0.00% | 620,000 | - | - | 1,029,000 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.59% | 0.14% | 483,583 | - | - | 802,748 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.47% | 0.00% | 385,149 | - | - | 639,347 | Jun 30, 2024 |
| MONACO ASSET MANAGEMENT SAM | 0.38% | 0.08% | 312,629 | - | - | 518,964 | Jun 30, 2024 |
| FRANKLIN STREET ADVISORS INC /NC | 0.18% | 0.02% | 150,000 | - | - | 249,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.18% | 0.00% | 148,357 | -180,632 | -54.91% | 246,273 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.13% | 0.00% | 106,703 | - | - | 177,127 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.10% | 0.00% | 84,733 | -67,769 | -44.44% | 140,657 | Jun 30, 2024 |
| MORGAN STANLEY | 0.10% | - | 77,942 | 10,351 | 15.31% | 129,384 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.09% | - | 73,163 | -36,944 | -33.55% | 121,451 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.08% | 0.00% | 68,945 | -9,999 | -12.67% | 114,449 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.08% | 0.00% | 61,900 | 61,900 | 100.00% | 102,754 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.06% | 0.00% | 51,501 | 16,500 | 47.14% | 85,492 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.06% | - | 46,671 | - | - | 77,473 | Jun 30, 2024 |
ProQR Therapeutics's largest institutional shareholder is PRIVIUM FUND MANAGEMENT B.V., holding 6.84% of the company's total share outstanding, currently valued at $9.21M. The top 10 institutional shareholders own together 19.46% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PRIVIUM FUND MANAGEMENT B.V. | 6.84% | 2.35% | 5,580,725 | 236,279 | 4.42% | 9,208,196 | Jun 30, 2024 |
| M28 CAPITAL MANAGEMENT LP | 1.25% | 2.19% | 1,019,498 | - | - | 1,692,367 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 1.10% | 0.47% | 900,000 | 900,000 | 100.00% | 1,494,000 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 1.11% | 0.36% | 905,582 | - | - | 1,503,266 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.59% | 0.14% | 483,583 | - | - | 802,748 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 2.50% | 0.10% | 2,042,771 | -841,586 | -29.18% | 3,391,000 | Jun 30, 2024 |
| MONACO ASSET MANAGEMENT SAM | 0.38% | 0.08% | 312,629 | - | - | 518,964 | Jun 30, 2024 |
| FRANKLIN STREET ADVISORS INC /NC | 0.18% | 0.02% | 150,000 | - | - | 249,000 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.44% | 0.01% | 3,625,467 | - | - | 6,018,275 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.13% | 0.00% | 106,703 | - | - | 177,127 | Jun 30, 2024 |
| ATOM INVESTORS LP | 0.02% | 0.00% | 13,107 | - | - | 21,758 | Jun 30, 2024 |
| RFG ADVISORY, LLC | 0.04% | 0.00% | 32,000 | - | - | 53,120 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.76% | 0.00% | 620,000 | - | - | 1,029,000 | Jun 30, 2024 |
| PFS PARTNERS, LLC | 0.00% | 0.00% | 1,000 | - | - | 1,660 | Jun 30, 2024 |
| CSENGE ADVISORY GROUP | 0.01% | 0.00% | 10,000 | - | - | 16,600 | Jun 30, 2024 |
| RESOURCES INVESTMENT ADVISORS, LLC. | 0.05% | 0.00% | 42,000 | -3,000 | -6.67% | 69,720 | Jun 30, 2024 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 0.03% | 0.00% | 21,429 | - | - | 35,572 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.08% | 0.00% | 61,900 | 61,900 | 100.00% | 102,754 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.47% | 0.00% | 385,149 | - | - | 639,347 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.08% | 0.00% | 68,945 | -9,999 | -12.67% | 114,449 | Jun 30, 2024 |
The largest ProQR Therapeutics shareholder by % of total assets is PRIVIUM FUND MANAGEMENT B.V.. The company owns 5.58M shares of ProQR Therapeutics (PRQR), representing 2.35% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GHOST TREE CAPITAL, LLC | 1.10% | 0.47% | 900,000 | 900,000 | 100.00% | 1,494,000 | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT B.V. | 6.84% | 2.35% | 5,580,725 | 236,279 | 4.42% | 9,208,196 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.08% | 0.00% | 61,900 | 61,900 | 100.00% | 102,754 | Jun 30, 2024 |
| UBS GROUP AG | 0.03% | - | 27,546 | 22,576 | 454.25% | 45,726 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.06% | 0.00% | 51,501 | 16,500 | 47.14% | 85,492 | Jun 30, 2024 |
| MORGAN STANLEY | 0.10% | - | 77,942 | 10,351 | 15.31% | 129,384 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 1,055 | 1,055 | 100.00% | 2,000 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | - | 821 | 821 | 100.00% | 1,363 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 33 | - | - | 55 | Jun 30, 2024 |
| BLACKROCK INC. | 0.00% | - | 3,945 | - | - | 6,549 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.01% | - | 10,996 | - | - | 18,253 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.06% | - | 46,671 | - | - | 77,473 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.04% | - | 30,000 | - | - | 53,400 | Jun 30, 2024 |
| MARINER, LLC | 0.02% | 0.00% | 18,334 | - | - | 30,434 | Jun 30, 2024 |
| KESTRA ADVISORY SERVICES, LLC | 0.01% | 0.00% | 10,000 | - | - | 16,600 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.47% | 0.00% | 385,149 | - | - | 639,347 | Jun 30, 2024 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 0.03% | 0.00% | 21,429 | - | - | 35,572 | Jun 30, 2024 |
| CSENGE ADVISORY GROUP | 0.01% | 0.00% | 10,000 | - | - | 16,600 | Jun 30, 2024 |
| PFS PARTNERS, LLC | 0.00% | 0.00% | 1,000 | - | - | 1,660 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.76% | 0.00% | 620,000 | - | - | 1,029,000 | Jun 30, 2024 |
As of Jun 30 2024, ProQR Therapeutics's largest institutional buyer is GHOST TREE CAPITAL, LLC. The company purchased 900.00K stocks of PRQR, valued at $1.49M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | 2.50% | 0.10% | 2,042,771 | -841,586 | -29.18% | 3,391,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.18% | 0.00% | 148,357 | -180,632 | -54.91% | 246,273 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.10% | 0.00% | 84,733 | -67,769 | -44.44% | 140,657 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.09% | - | 73,163 | -36,944 | -33.55% | 121,451 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -25,943 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.00% | - | 3,933 | -20,830 | -84.12% | 6,000 | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -12,053 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.02% | 0.00% | 12,471 | -11,262 | -47.45% | 20,702 | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.08% | 0.00% | 68,945 | -9,999 | -12.67% | 114,449 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.01% | - | 6,628 | -6,922 | -51.08% | 11,000 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.01% | - | 4,090 | -5,600 | -57.79% | 6,789,000 | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -4,147 | -100.00% | - | Jun 30, 2024 |
| RESOURCES INVESTMENT ADVISORS, LLC. | 0.05% | 0.00% | 42,000 | -3,000 | -6.67% | 69,720 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.02% | - | 15,932 | -1,488 | -8.54% | 26,448,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 314 | -1,179 | -78.97% | 521 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 12,250 | -561 | -4.38% | 20,335 | Jun 30, 2024 |
| M28 CAPITAL MANAGEMENT LP | 1.25% | 2.19% | 1,019,498 | - | - | 1,692,367 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 1.11% | 0.36% | 905,582 | - | - | 1,503,266 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.59% | 0.14% | 483,583 | - | - | 802,748 | Jun 30, 2024 |
As of Jun 30 2024, ProQR Therapeutics's biggest institutional seller is ECOR1 CAPITAL, LLC. The company sold -0.84M shares of PRQR, valued at $3.39M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GHOST TREE CAPITAL, LLC | 1.10% | 0.47% | 900,000 | 900,000 | 100.00% | 1,494,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.08% | 0.00% | 61,900 | 61,900 | 100.00% | 102,754 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 1,055 | 1,055 | 100.00% | 2,000 | Jun 30, 2024 |
ProQR Therapeutics's largest new institutional shareholder by number of shares is GHOST TREE CAPITAL, LLC, purchased 900.00K shares, valued at $1.49M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIRTU FINANCIAL LLC | - | - | - | -25,943 | -100.00% | - | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -12,053 | -100.00% | - | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -4,147 | -100.00% | - | Jun 30, 2024 |
ProQR Therapeutics's largest sold out institutional shareholder by shares sold is VIRTU FINANCIAL LLC, sold -25.94K shares, valued at -, as of undefined.
ProQR Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| DRIEHAUS MUTUAL FUNDS | 0.02% | 223,726 | - | - | Mar 28, 2024 |
| ALPS ETF Trust | 0.01% | 69,542 | - | - | Feb 29, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 300,452 | - | - | Feb 29, 2024 |
| Global X Funds | 0.00% | 174,189 | - | - | Jan 31, 2024 |
| VANGUARD WHITEHALL FUNDS | 0.00% | 146,867 | - | - | Jan 31, 2024 |
| RBB FUND, INC. | 0.00% | 126,755 | - | - | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 27,145 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 21,124 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 63,953 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 6,172 | - | - | Mar 28, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 205 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 185 | 98 | 112.64% | Feb 29, 2024 |
ProQR Therapeutics's largest mutual fund holder by % of total assets is "DRIEHAUS MUTUAL FUNDS", owning 223.73K shares, compromising 0.02% of its total assets.
ProQR Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 11 | -78.43% |
| 31 Mar, 24 | 51 | 6.25% |
| 31 Dec, 23 | 48 | 6.67% |
| 30 Sep, 23 | 45 | -15.09% |
| 30 Jun, 23 | 53 | -7.02% |
| 31 Mar, 23 | 57 | 11.76% |
| 31 Dec, 22 | 51 | 8.51% |
| 30 Sep, 22 | 47 | -7.84% |
| 30 Jun, 22 | 51 | -25.00% |
| 31 Mar, 22 | 68 | -15.00% |
| 31 Dec, 21 | 80 | 12.68% |
| 30 Sep, 21 | 71 | 10.94% |
| 30 Jun, 21 | 64 | -9.86% |
| 31 Mar, 21 | 71 | 47.92% |
| 31 Dec, 20 | 48 | 14.29% |
| 30 Sep, 20 | 42 | -8.70% |
| 30 Jun, 20 | 46 | -2.13% |
| 31 Mar, 20 | 47 | -9.62% |
| 31 Dec, 19 | 52 | 6.12% |
| 30 Sep, 19 | 49 | -12.50% |
| 30 Jun, 19 | 56 | 3.70% |
| 31 Mar, 19 | 54 | -5.26% |
| 31 Dec, 18 | 57 | 62.86% |
| 30 Sep, 18 | 35 | 40.00% |
| 30 Jun, 18 | 25 | - |
| 31 Mar, 18 | 25 | -3.85% |
| 31 Dec, 17 | 26 | 18.18% |
| 30 Sep, 17 | 22 | 22.22% |
| 30 Jun, 17 | 18 | -10.00% |
| 31 Mar, 17 | 20 | -9.09% |
| 31 Dec, 16 | 22 | -12.00% |
| 30 Sep, 16 | 25 | -3.85% |
| 30 Jun, 16 | 26 | -10.34% |
| 31 Mar, 16 | 29 | -9.38% |
| 31 Dec, 15 | 32 | -8.57% |
| 30 Sep, 15 | 35 | -2.78% |
| 30 Jun, 15 | 36 | -5.26% |
| 31 Mar, 15 | 38 | 8.57% |
| 31 Dec, 14 | 35 | 16.67% |
| 30 Sep, 14 | 30 | - |
As of 30 Jun 24, 11 institutions are holding ProQR Therapeutics's shares, representing a decrease of -78.43% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 6,805,586 | -60.86% |
| 31 Mar, 24 | 17,387,495 | -5.46% |
| 31 Dec, 23 | 18,391,472 | -1.74% |
| 30 Sep, 23 | 18,716,284 | -11.45% |
| 30 Jun, 23 | 21,135,789 | -5.25% |
| 31 Mar, 23 | 22,307,774 | 33.74% |
| 31 Dec, 22 | 16,679,399 | -21.48% |
| 30 Sep, 22 | 21,242,505 | -4.10% |
| 30 Jun, 22 | 22,151,720 | -30.26% |
| 31 Mar, 22 | 31,763,460 | -36.74% |
| 31 Dec, 21 | 50,211,379 | 26.06% |
| 30 Sep, 21 | 39,831,788 | 3.51% |
| 30 Jun, 21 | 38,480,904 | -11.43% |
| 31 Mar, 21 | 43,445,443 | 64.48% |
| 31 Dec, 20 | 26,413,798 | -5.71% |
| 30 Sep, 20 | 28,012,830 | -3.76% |
| 30 Jun, 20 | 29,108,389 | -0.78% |
| 31 Mar, 20 | 29,336,360 | -2.70% |
| 31 Dec, 19 | 30,150,188 | 39.18% |
| 30 Sep, 19 | 21,662,813 | -8.32% |
| 30 Jun, 19 | 23,627,913 | -1.55% |
| 31 Mar, 19 | 24,000,266 | 3.88% |
| 31 Dec, 18 | 23,104,626 | 18.39% |
| 30 Sep, 18 | 19,515,607 | 76.30% |
| 30 Jun, 18 | 11,069,786 | 3.57% |
| 31 Mar, 18 | 10,688,405 | -7.12% |
| 31 Dec, 17 | 11,508,313 | 14.20% |
| 30 Sep, 17 | 10,077,120 | 11.93% |
| 30 Jun, 17 | 9,003,272 | -0.08% |
| 31 Mar, 17 | 9,010,116 | 1.36% |
| 31 Dec, 16 | 8,889,119 | 2.26% |
| 30 Sep, 16 | 8,692,509 | -5.01% |
| 30 Jun, 16 | 9,151,395 | -4.99% |
| 31 Mar, 16 | 9,632,200 | -13.92% |
| 31 Dec, 15 | 11,189,723 | 0.47% |
| 30 Sep, 15 | 11,137,806 | 2.79% |
| 30 Jun, 15 | 10,835,771 | -1.63% |
| 31 Mar, 15 | 11,015,140 | 37.38% |
| 31 Dec, 14 | 8,018,201 | 5.12% |
| 30 Sep, 14 | 7,627,734 | - |
ProQR Therapeutics (PRQR) has 6.81M shares outstanding as of 30 Jun 24, down -60.86% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 8.34% | 1.70% |
| 31 Mar, 24 | 22.16% | 4.30% |
| 31 Dec, 23 | 22.71% | 4.25% |
| 30 Sep, 23 | 23.12% | 3.39% |
| 30 Jun, 23 | 26.13% | 3.44% |
| 31 Mar, 23 | 27.58% | 5.09% |
| 31 Dec, 22 | 23.28% | 2.63% |
| 30 Sep, 22 | 29.76% | 3.09% |
| 30 Jun, 22 | 31.04% | 1.57% |
| 31 Mar, 22 | 44.51% | 0.90% |
| 31 Dec, 21 | 70.48% | 2.07% |
| 30 Sep, 21 | 58.35% | 1.72% |
| 30 Jun, 21 | 58.17% | 0.80% |
| 31 Mar, 21 | 85.50% | 3.07% |
| 31 Dec, 20 | 52.76% | 1.69% |
| 30 Sep, 20 | 55.87% | 1.65% |
| 30 Jun, 20 | 58.19% | 1.68% |
| 31 Mar, 20 | 58.78% | 1.09% |
| 31 Dec, 19 | 73.47% | 2.37% |
| 30 Sep, 19 | 55.67% | 1.51% |
| 30 Jun, 19 | 60.73% | 1.59% |
| 31 Mar, 19 | 61.72% | 1.34% |
| 31 Dec, 18 | 67.85% | 1.98% |
| 30 Sep, 18 | 58.51% | 4.87% |
| 30 Jun, 18 | 34.67% | 3.09% |
| 31 Mar, 18 | 33.48% | 1.63% |
| 31 Dec, 17 | 45.35% | 2.85% |
| 30 Sep, 17 | 39.86% | 2.83% |
| 30 Jun, 17 | 37.53% | 2.55% |
| 31 Mar, 17 | 38.38% | 2.65% |
| 31 Dec, 16 | 38.07% | 2.75% |
| 30 Sep, 16 | 37.23% | 2.42% |
| 30 Jun, 16 | 39.20% | 2.30% |
| 31 Mar, 16 | 41.26% | 1.80% |
| 31 Dec, 15 | 47.94% | 2.11% |
| 30 Sep, 15 | 47.71% | 2.21% |
| 30 Jun, 15 | 46.42% | 2.08% |
| 31 Mar, 15 | 47.20% | 4.00% |
| 31 Dec, 14 | 34.36% | 3.22% |
| 30 Sep, 14 | 32.68% | - |
As of 30 Jun 24, ProQR Therapeutics is held by 8.34% institutional shareholders, representing a 1.70% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | -92.86% |
| 31 Mar, 24 | 14 | 16.67% |
| 31 Dec, 23 | 12 | 9.09% |
| 30 Sep, 23 | 11 | -45.00% |
| 30 Jun, 23 | 20 | -42.86% |
| 31 Mar, 23 | 35 | 34.62% |
| 31 Dec, 22 | 26 | 62.50% |
| 30 Sep, 22 | 16 | -33.33% |
| 30 Jun, 22 | 24 | -38.46% |
| 31 Mar, 22 | 39 | -13.33% |
| 31 Dec, 21 | 45 | 15.38% |
| 30 Sep, 21 | 39 | 14.71% |
| 30 Jun, 21 | 34 | -29.17% |
| 31 Mar, 21 | 48 | 100.00% |
| 31 Dec, 20 | 24 | 50.00% |
| 30 Sep, 20 | 16 | -33.33% |
| 30 Jun, 20 | 24 | 26.32% |
| 31 Mar, 20 | 19 | -51.28% |
| 31 Dec, 19 | 39 | 85.71% |
| 30 Sep, 19 | 21 | -8.70% |
| 30 Jun, 19 | 23 | -8.00% |
| 31 Mar, 19 | 25 | -35.90% |
| 31 Dec, 18 | 39 | 77.27% |
| 30 Sep, 18 | 22 | 83.33% |
| 30 Jun, 18 | 12 | 20.00% |
| 31 Mar, 18 | 10 | -33.33% |
| 31 Dec, 17 | 15 | 7.14% |
| 30 Sep, 17 | 14 | 55.56% |
| 30 Jun, 17 | 9 | 50.00% |
| 31 Mar, 17 | 6 | -33.33% |
| 31 Dec, 16 | 9 | 12.50% |
| 30 Sep, 16 | 8 | -20.00% |
| 30 Jun, 16 | 10 | -16.67% |
| 31 Mar, 16 | 12 | -14.29% |
| 31 Dec, 15 | 14 | -33.33% |
| 30 Sep, 15 | 21 | 10.53% |
| 30 Jun, 15 | 19 | -20.83% |
| 31 Mar, 15 | 24 | 20.00% |
| 31 Dec, 14 | 20 | -33.33% |
| 30 Sep, 14 | 30 | - |
1 institutional shareholders have increased their position in PRQR stock as of 30 Jun 24 compared to 14 in the previous quarter (a -92.86% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -80.00% |
| 31 Mar, 24 | 15 | 25.00% |
| 31 Dec, 23 | 12 | 9.09% |
| 30 Sep, 23 | 11 | 10.00% |
| 30 Jun, 23 | 10 | 150.00% |
| 31 Mar, 23 | 4 | -71.43% |
| 31 Dec, 22 | 14 | -22.22% |
| 30 Sep, 22 | 18 | 28.57% |
| 30 Jun, 22 | 14 | -6.67% |
| 31 Mar, 22 | 15 | -37.50% |
| 31 Dec, 21 | 24 | 41.18% |
| 30 Sep, 21 | 17 | - |
| 30 Jun, 21 | 17 | 88.89% |
| 31 Mar, 21 | 9 | -35.71% |
| 31 Dec, 20 | 14 | -17.65% |
| 30 Sep, 20 | 17 | 30.77% |
| 30 Jun, 20 | 13 | -31.58% |
| 31 Mar, 20 | 19 | 111.11% |
| 31 Dec, 19 | 9 | -25.00% |
| 30 Sep, 19 | 12 | -33.33% |
| 30 Jun, 19 | 18 | 20.00% |
| 31 Mar, 19 | 15 | 15.38% |
| 31 Dec, 18 | 13 | 30.00% |
| 30 Sep, 18 | 10 | 66.67% |
| 30 Jun, 18 | 6 | - |
| 31 Mar, 18 | 6 | - |
| 31 Dec, 17 | 6 | 20.00% |
| 30 Sep, 17 | 5 | 400.00% |
| 30 Jun, 17 | 1 | -80.00% |
| 31 Mar, 17 | 5 | -28.57% |
| 31 Dec, 16 | 7 | -36.36% |
| 30 Sep, 16 | 11 | 10.00% |
| 30 Jun, 16 | 10 | 11.11% |
| 31 Mar, 16 | 9 | -25.00% |
| 31 Dec, 15 | 12 | 50.00% |
| 30 Sep, 15 | 8 | -38.46% |
| 30 Jun, 15 | 13 | 44.44% |
| 31 Mar, 15 | 9 | -18.18% |
| 31 Dec, 14 | 11 | - |
| 30 Sep, 14 | - | - |
3 institutional shareholders have reduced their position in PRQR stock as of 30 Jun 24 compared to 15 in the previous quarter (a -80.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 11 | -78.43% | 6,805,586 | -60.86% | 8.34% | 1.70% | 1 | -92.86% | 3 | -80.00% |
| 31 Mar, 24 | 51 | 6.25% | 17,387,495 | -5.46% | 22.16% | 4.30% | 14 | 16.67% | 15 | 25.00% |
| 31 Dec, 23 | 48 | 6.67% | 18,391,472 | -1.74% | 22.71% | 4.25% | 12 | 9.09% | 12 | 9.09% |
| 30 Sep, 23 | 45 | -15.09% | 18,716,284 | -11.45% | 23.12% | 3.39% | 11 | -45.00% | 11 | 10.00% |
| 30 Jun, 23 | 53 | -7.02% | 21,135,789 | -5.25% | 26.13% | 3.44% | 20 | -42.86% | 10 | 150.00% |
| 31 Mar, 23 | 57 | 11.76% | 22,307,774 | 33.74% | 27.58% | 5.09% | 35 | 34.62% | 4 | -71.43% |
| 31 Dec, 22 | 51 | 8.51% | 16,679,399 | -21.48% | 23.28% | 2.63% | 26 | 62.50% | 14 | -22.22% |
| 30 Sep, 22 | 47 | -7.84% | 21,242,505 | -4.10% | 29.76% | 3.09% | 16 | -33.33% | 18 | 28.57% |
| 30 Jun, 22 | 51 | -25.00% | 22,151,720 | -30.26% | 31.04% | 1.57% | 24 | -38.46% | 14 | -6.67% |
| 31 Mar, 22 | 68 | -15.00% | 31,763,460 | -36.74% | 44.51% | 0.90% | 39 | -13.33% | 15 | -37.50% |
| 31 Dec, 21 | 80 | 12.68% | 50,211,379 | 26.06% | 70.48% | 2.07% | 45 | 15.38% | 24 | 41.18% |
| 30 Sep, 21 | 71 | 10.94% | 39,831,788 | 3.51% | 58.35% | 1.72% | 39 | 14.71% | 17 | - |
| 30 Jun, 21 | 64 | -9.86% | 38,480,904 | -11.43% | 58.17% | 0.80% | 34 | -29.17% | 17 | 88.89% |
| 31 Mar, 21 | 71 | 47.92% | 43,445,443 | 64.48% | 85.50% | 3.07% | 48 | 100.00% | 9 | -35.71% |
| 31 Dec, 20 | 48 | 14.29% | 26,413,798 | -5.71% | 52.76% | 1.69% | 24 | 50.00% | 14 | -17.65% |
| 30 Sep, 20 | 42 | -8.70% | 28,012,830 | -3.76% | 55.87% | 1.65% | 16 | -33.33% | 17 | 30.77% |
| 30 Jun, 20 | 46 | -2.13% | 29,108,389 | -0.78% | 58.19% | 1.68% | 24 | 26.32% | 13 | -31.58% |
| 31 Mar, 20 | 47 | -9.62% | 29,336,360 | -2.70% | 58.78% | 1.09% | 19 | -51.28% | 19 | 111.11% |
| 31 Dec, 19 | 52 | 6.12% | 30,150,188 | 39.18% | 73.47% | 2.37% | 39 | 85.71% | 9 | -25.00% |
| 30 Sep, 19 | 49 | -12.50% | 21,662,813 | -8.32% | 55.67% | 1.51% | 21 | -8.70% | 12 | -33.33% |
| 30 Jun, 19 | 56 | 3.70% | 23,627,913 | -1.55% | 60.73% | 1.59% | 23 | -8.00% | 18 | 20.00% |
| 31 Mar, 19 | 54 | -5.26% | 24,000,266 | 3.88% | 61.72% | 1.34% | 25 | -35.90% | 15 | 15.38% |
| 31 Dec, 18 | 57 | 62.86% | 23,104,626 | 18.39% | 67.85% | 1.98% | 39 | 77.27% | 13 | 30.00% |
| 30 Sep, 18 | 35 | 40.00% | 19,515,607 | 76.30% | 58.51% | 4.87% | 22 | 83.33% | 10 | 66.67% |
| 30 Jun, 18 | 25 | - | 11,069,786 | 3.57% | 34.67% | 3.09% | 12 | 20.00% | 6 | - |
| 31 Mar, 18 | 25 | -3.85% | 10,688,405 | -7.12% | 33.48% | 1.63% | 10 | -33.33% | 6 | - |
| 31 Dec, 17 | 26 | 18.18% | 11,508,313 | 14.20% | 45.35% | 2.85% | 15 | 7.14% | 6 | 20.00% |
| 30 Sep, 17 | 22 | 22.22% | 10,077,120 | 11.93% | 39.86% | 2.83% | 14 | 55.56% | 5 | 400.00% |
| 30 Jun, 17 | 18 | -10.00% | 9,003,272 | -0.08% | 37.53% | 2.55% | 9 | 50.00% | 1 | -80.00% |
| 31 Mar, 17 | 20 | -9.09% | 9,010,116 | 1.36% | 38.38% | 2.65% | 6 | -33.33% | 5 | -28.57% |
| 31 Dec, 16 | 22 | -12.00% | 8,889,119 | 2.26% | 38.07% | 2.75% | 9 | 12.50% | 7 | -36.36% |
| 30 Sep, 16 | 25 | -3.85% | 8,692,509 | -5.01% | 37.23% | 2.42% | 8 | -20.00% | 11 | 10.00% |
| 30 Jun, 16 | 26 | -10.34% | 9,151,395 | -4.99% | 39.20% | 2.30% | 10 | -16.67% | 10 | 11.11% |
| 31 Mar, 16 | 29 | -9.38% | 9,632,200 | -13.92% | 41.26% | 1.80% | 12 | -14.29% | 9 | -25.00% |
| 31 Dec, 15 | 32 | -8.57% | 11,189,723 | 0.47% | 47.94% | 2.11% | 14 | -33.33% | 12 | 50.00% |
| 30 Sep, 15 | 35 | -2.78% | 11,137,806 | 2.79% | 47.71% | 2.21% | 21 | 10.53% | 8 | -38.46% |
| 30 Jun, 15 | 36 | -5.26% | 10,835,771 | -1.63% | 46.42% | 2.08% | 19 | -20.83% | 13 | 44.44% |
| 31 Mar, 15 | 38 | 8.57% | 11,015,140 | 37.38% | 47.20% | 4.00% | 24 | 20.00% | 9 | -18.18% |
| 31 Dec, 14 | 35 | 16.67% | 8,018,201 | 5.12% | 34.36% | 3.22% | 20 | -33.33% | 11 | - |
| 30 Sep, 14 | 30 | - | 7,627,734 | - | 32.68% | - | 30 | - | - | - |
ProQR Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ARWR | Arrowhead Pharmaceuticals, Inc. |
| NUVB | Nuvation Bio Inc. |
| ACHL | Achilles Therapeutics plc |
| NXTC | NextCure, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| CTMX | CytomX Therapeutics, Inc. |
| SPRO | Spero Therapeutics, Inc. |
| ALNY | Alnylam Pharmaceuticals, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| ANNX | Annexon, Inc. |
| ASMB | Assembly Biosciences, Inc. |
| WVE | Wave Life Sciences Ltd. |
| NLTX | Neurogene Inc. |
| TIL | Instil Bio, Inc. |
PRQR Ownership FAQ
Who Owns ProQR Therapeutics?
ProQR Therapeutics is owned by institutional shareholders (8.34%), insiders (18.22%), and public (73.44%). The largest institutional shareholder of ProQR Therapeutics is PRIVIUM FUND MANAGEMENT B.V. (6.84% of total shares) and the top mutual fund owner is DRIEHAUS MUTUAL FUNDS (0.02% of total shares).
Who are the major institutional shareholders of ProQR Therapeutics?
ProQR Therapeutics's major institutional shareholders are PRIVIUM FUND MANAGEMENT B.V., ADAGE CAPITAL PARTNERS GP, L.L.C., ECOR1 CAPITAL, LLC, M28 CAPITAL MANAGEMENT LP, and DAFNA CAPITAL MANAGEMENT LLC. The top five shareholders own together 16.15% of the company's share outstanding.
How many ProQR Therapeutics shareholders are there?
As of Jun 2024, there are 11 institutional shareholders of ProQR Therapeutics.
What percentage of ProQR Therapeutics is owned by PRIVIUM FUND MANAGEMENT B.V?
PRIVIUM FUND MANAGEMENT B.V owns 5.58M shares of ProQR Therapeutics, representing 6.84% of the company's total shares outstanding, valued at $9.21M (as of Jun 2024).
What percentage of ProQR Therapeutics is owned by ADAGE CAPITAL PARTNERS GP, L.L.C?
As of Jun 2024, ADAGE CAPITAL PARTNERS GP, L.L.C holds 3.63M shares of ProQR Therapeutics (PRQR), compromising 4.44% of the company, valued at $6.02M.
What percentage of ProQR Therapeutics is owned by ECOR1 CAPITAL, LLC?
ECOR1 CAPITAL, LLC is the third largest holder of ProQR Therapeutics. The company owns 2.04M of the company's shares outstanding (worth $3.39M).